Functional implications of multiple dopamine receptor subtypes: The D1/D3 receptor coexistence

Brain Research Reviews

Volumn 26, Issue 2-3, 1998, Pages 236-242

  Schwartz, Jean Charles ^a   Diaz, Jorge ^b   Bordet, Régis ^b   Griffon, Nathalie ^a   Perachon, Sylvie ^a   Pilon, Catherine ^a   Ridray, Sophie ^b   Sokoloff, Pierre ^a  

^a CENTRE PAUL BROCA   (France)

^b Faculté de Pharmacie ^*  (France)

Author keywords

Antipsychotics; Behavioral sensitization; D1 D3 receptor interactions; Dopamine D3 receptor; Parkinson's disease; Schizophrenia

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 3 RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL CELL; ANIMAL TISSUE; CONFERENCE PAPER; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; NONHUMAN; NUCLEUS ACCUMBENS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR DENSITY; SCHIZOPHRENIA;

ANIMALS; CORPUS STRIATUM; HUMANS; NEUROPEPTIDES; NUCLEUS ACCUMBENS; PROTEIN PRECURSORS; RATS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TACHYKININS; TRANSCRIPTION, GENETIC;

EID: 0032079084     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(97)00046-5     Document Type: Conference Paper

References (36)

1. 3 receptor expression as a mechanism of behavioral sensitization to levodopa. Proc. Natl. Acad. Sci. USA. 94:1997;3363-3367.
2. 2 receptor mRNA. Brain Res. 564:1991;203-219.
3. Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacol. 1:1988;179-186.
4. Carlsson A., Bouthenet M.L. Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol. Toxicol. 20:1963;140-144.
5. 2 dopamine receptors. Mol. Pharmacol. 45:1994;51-60.
6. Cole D.G., Kobierski L.A., Konradi C., Hyman S.E. 6-Hydroxydopamine lesions of the rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons. Proc. Natl. Acad. Sci. USA. 91:1994;9631-9635.
7. 3 receptor gene. J. Med. Genet. 29:1992;858-860.
8. 3 receptors on neurotensin mRNA expression in nucleus accumbens. Eur. J. Neurosci. 6:1994;1384-1387.
9. 3 receptor. Neuroscience. 65:1995;731-745.
10. 3 receptor mRNA in proliferative zones during embryonic development of the rat brain. J. Neurosci. 17:1997;4282-4292.
11. 2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology. 99:1989;S28-S31.
12. 1 dopamine receptor mRNA in brain supports a role in cognitive, affective and neuroendocrine aspects of dopaminergic neurotransmission. Proc. Natl. Acad. Sci. USA. 88:1991;3772-3776.
13. 3 receptor gene: organization, transcript variants and polymorphism associated with schizophrenia. Am. J. Med. Genet. [Neuropsychiatric Genetics]. 67:1996;58-70.
14. 3 receptor: opposite and synergistic interactions with cyclic AMP. J. Neurochem. 67:1997;1-9.
15. H.J. Groenewegen, H.W. Berendse, G.E. Meredith, S.N. Haber, P. Voorn, J.G. Wolters, A.H.M. Lohman, Functional anatomy of the ventral, limbic system-innervated striatum, in: P. Willner, J. Scheel-Kruger (Eds.), The Mesolimbic Dopamine System: From motivation to action, Wiley, Chichester, 1991, pp. 19-59.
16. 3 receptors and use of antipsychotics in patients with schizophrenia. Arch. Gen. Psychiatry. 54:1997;225-232.
17. 1 dopamine receptor in rat brain reveals its axonal transport, pre- and post-synaptic localization, and prevalence in the basal ganglia, limbic system and thalamic reticular nucleus. Proc. Natl. Acad. Sci. USA. 89:1992;11988-11992.
18. Jaskin, G.E., Weinberger, D.R., Dopamine and schizophrenia - acortically corrected perspective, 1992.
19. Kavanaugh W.M., Lewis L.T., Ives H.E., Coughlin S.H. Serotonin-induced deoxyribonucleic acid synthesis in vascular smooth muscle cells involved in a novel, pertussis toxin-sensitive pathway. Mol. Endocrinol. 2:1988;599-605.
20. 4 dopamine receptors determined in transfected cells. Clin. Pharmacol. 18:1995;S25-S33.
21. 3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatric Genetics. 2:1992;249-256.
22. 3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. Proc. Natl. Acad. Sci. USA. 92:1995;1719-1723.
23. Merchant K.M., Dorsa D.M. Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics. Proc. Natl. Acad. Sci. 90:1993;3447-3451.
24. Murray R.M. Neurodevelopmental schizophrenia: the rediscovery of a dementia-praecox. Br. J. Psychiatry. 165:1994;6-12.
25. 1 receptors in schizophrenia revealed by PET. Nature. 385:1997;634-636.
26. 3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line. Eur. J. Pharmacol. [Mol. Pharmacol. Sect.]. 268:1994;129-139.
27. Robertson G.S., Herrera D.G., Dragunow M., Robertson H.A. L-dopa activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra. Eur. J. Pharmacol. 159:1989;99-100.
28. 3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia. Proc. Natl. Acad. Sci. USA. 90:1993;8942-8946.
29. Schwartz J.-C., Giros B., Martres M.P., Sokoloff P. The dopamine receptor family: molecular biology and pharmacology. Sem. Neurosci. 4:1992;99-108.
30. Sedvall G., Farde L. Chemical brain anatomy in schizophrenia. Lancet. 346:1995;743-749.
31. Sibley D.R., Monsma F.J. Molecular biology of dopamine receptors. Trends Pharmacol. Sci. 13:1992;61-65.
32. Snyder S.H. The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. Am. J. Psychiatry. 133:1976;197-202.
33. 3) as a target for neuroleptics. Nature. 347:1990;146-151.
34. Sokoloff P., Schwartz J.C. The novel dopamine receptors half a decade later. Trends Pharmacol. Sci. 16:1995;270-275.
35. van Corven E.J., Groenink A., Jalink K., Eicholtz T., Moolenaar W.H. Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell. 59:1989;45.
36. Zahm D.S., Brog J.S. On the significance of subterritories in the "accumbens" part of the rat ventral striatum. Neuroscience. 50:1992;751-767.